Exclusive

Publication

Byline

Location

Xencor Stock Surges 24%

India, Oct. 26 -- Xencor, Inc. (XNCR) is up 23.87 percent, gaining $6.01 to $31.19 on Monday. The surge appears to follow positive clinical data announced Sunday for XmAb819, the company's investigati... Read More


Scienjoy Holding H1 Income Rises

India, Oct. 26 -- On Monday, Scienjoy Holding Corporation (SJ) reported higher income in the first half of 2026, compared to the same half last year. Net income attributable to the shareholders rose ... Read More


TransCode Reports Phase 1a Data For TTX-MC138 In Advanced Solid Tumors

India, Oct. 26 -- TransCode Therapeutics, Inc. (RNAZ) presented Phase 1a clinical data for TTX-MC138, an investigational RNA-based therapy targeting metastatic cancers, at the European Society for Med... Read More


Oruka Therapeutics Stock Jumps 12% After Positive Phase 2b Psoriasis Trial

India, Oct. 26 -- Oruka Therapeutics, Inc. (ORKA) is up 11.69 percent, gaining $9.37 to $89.52 on Monday. The rise follows positive Week 16 results from the company's EVERLAST-B Phase 2b trial evaluat... Read More


Can-Fite Presents Final Phase 2a Data For Namodenoson In Pancreatic Cancer

India, Oct. 26 -- Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing small molecule therapeutics, announced the final data from its Phase 2a clinical study of namodenoso... Read More


Anthropic Announces SEC Filing For Proposed IPO

India, Oct. 26 -- Monday, Anthropic (ANT) announced its plan to list its Class A common stock on the Nasdaq Global Select Market under the symbol 'ANT.' As part of the plan, the AI giant has filed a ... Read More


Biohaven's BHV-1420 Targets PLA2R Autoantibodies In Membranous Nephropathy

India, Oct. 26 -- Biohaven Ltd. (BHVN) presented preclinical data for BHV-1420, an investigational drug designed to selectively remove the autoantibodies that drive membranous nephropathy, at the Amer... Read More


Bayer's Asundexian Becomes First Factor XIa Inhibitor Approved In China For Stroke Prevention

India, Oct. 26 -- Bayer said China's National Medical Products Administration (NMPA) has approved Asundexian 50 mg, marketed as Sunharbo, to reduce the risk of stroke in adults who have experienced a ... Read More


Range Resources Shares Surge 16% On $50 Bln EQT Merger Deal

India, Oct. 26 -- Shares of Range Resources (RRC) on Monday surged about 16% after EQT Corporation agreed to acquire the natural gas producer in an all-stock transaction that will create a combined co... Read More


Surgery Partners To Be Acquired By HealthSpan Partners In $5.7 Bln Deal; Shares Jump

India, Oct. 26 -- Outpatient surgical facility operator Surgery Partners, Inc. (SGRY) announced on Monday that it has agreed to be acquired by HealthSpan Partners in an all-cash transaction valued at ... Read More